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Summary.-I.p. administration of 14 mg Corynebacterium parvum (C. parvum)
24 h before inoculation of Landschutz ascites carcinoma (LAC) cells significantly
impaired growth of the tumour in MF1 mice. The injection of tumour cells caused a
transient inhibition of the activity of the mononuclear phagocyte system (MPS)
in both normal and C. parvum-treated hosts, as evidenced by impaired clearance of
colloidal carbon from the bloodstream and reduction in hepatic phagocytosis of
51Cr-labelled sheep erythrocytes. Depression in Kupffer-cell activity was associated
with a shift in particle distribution towards the spleen. The pronounced hepato-
splenomegaly in response to C. parvum was significantly less in animals which also
received tumour cells. Histological examination of liver and spleen revealed evidence
of depressed MPS activity. Granuloma production in the liver in response to C. par-
vum was inhibited in tumour-bearing mice, and macrophage proliferation within
the spleen was also reduced. Ascitic fluid showed similar inhibitory effects to those of
tumour-cell suspensions, suggesting production byLACofaheat-stable macrophage-
inhibitory factor.
THE CAPACITY of Corynebacterium par-
vum (C. parvum) to increase host resist-
ance to experimental tumours is well
documented (Milas & Scott, 1978). This
property is generally attributed to the
marked stimulation of the mononuclear
phagocyte system (MPS) by the micro-
organism (Halpern et al., 1963; Adlam &
Scott, 1973).
There is substantial evidence that
macrophages play an important role in
tumour immunity (Levy & Wheelock,
1974; Alexander, 1976; Nelson et al., 1978;
Weinberg & Hibbs, 1978) and it has been
suggested that they are mediators of
immunological surveillance (Alexander,
1976). However, there are reports (re-
viewed by James, 1977 and North et al.,
1978) that malignant tumour cells, or
their soluble products, can interfere with
normal macrophage functions, such as
phagocytosis, bacterial resistance and
chemotaxis. As yet, there is little informa-
tion on the influence oftumour carriage on
MPS activity in animals treated with C.
parvum or other immunotherapeutic
agents. In this paper we report the in-
fluence of the Landschutz ascites carci-
noma on MPS activity in normal and C.
parvum-injected mice. We have also
attempted to verify the observation of
Hrsak & Marotti (1974) and Normann
(1978) that ascitic fluid can depress
macrophage function in vivo.
MATERIALS AND METHODS
Mice.-Closed-colony bred 12-24-week-old
female MFI mice (mean wrt 28 g) wvere used
throughout. They w%vere bred in the Universitv
Animal Department. Foresterhill, Aberdeen,
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maintained in a temperature-controlled en-
vironment and received Oxoid rat and mouse
breeding diet with tap wrater ad libitum. C.
parvumr Strain CN6134 was supplied by
Wellcome Reagents Ltd, Beckenham, Kent,
as formalin-killed material (Batch Number
CA 761) at a concentration of7 mg dry weight
washed C. parvrun per ml pyrogen-free
physiological saline, -with 0.010% thiomersal
(phenylmercuric nitrate) as preservative. The
preparation was stored at 4°C and mice
received 14 mg i.p. alone or 24-96 h before
tumour-cell injection. Controls were injected
with an equivalent volume of Dulbeeco A
phosphate-buffered saline (PBS).
Tumour.-The Landschiitz ascites carci-
noma, a non-strain-specific subline of the
Ehrlich diploid careinoma (Tjio & Levan,
1954) was propagated by ip. injection of
0-2 ml undiluted cell suspensions obtained by
peritoneal aspiration on the 7th day oftumour
development. The total number of cells in-
jected w%as 18-4 + P8 x 106 and viability,
estimated by trypan-blue dye exclusion,
always exceeded 96%.
Cell-free ascitesfluid. Peritoneal fluid was
collected from ascitic mice 11 days after
tumour injection and centrifuged for 30 min
at 12,000 g (Normann, 1978). The cell-free
supernatant was stored at -20°C and thawed
just before use. The protein concentration,
estimated by the method of Lowry, was 22-2
mg/ml, and mice received 1 ml i.p.
Determination ofthe phagocytic index (K).-
The rate of clearance of colloidal carbon from
the bloodstream was used as a measure ofthe
phagoeytie index (K) (Biozzi et al., 1953).
Each mouse received a single i.v. injection
via a lateral tail vein of 0 3 ml colloidal
carbon (518, Gunther Wagner, Pelikan-
Wrerke, Hannover, Germany) containing 100
tnl original carbon suspension (1 part carbon
suspension to 2 parts 1% autoclaved Difco
gelatin in distilled w%vater). The amount of
carbon injected was -16 mg/100 g body wt.
Ten-,ul blood samples were then taken under
light ether anaesthesia from the retro-orbital
venous plexus, using disposable heparinized
(Pularin; Duncan, Flockhart & Co. Ltd)
micropipettes (Drummond "Microcaps"). Five
or 6 samples, obtained at regular intervals
over 30-75 min (depending on the rate of
clearance) were each lysed in 3 ml 1% Triton
X100. The optical density w,as then measured
using a Cecil UV spectrophotometer at 800
nm w%ith a lcm path length. Optical density
was plotted against time on semi-log paper,
and the half-time for carbon disappearance
(ti) obtained from a straight line fitted by
eye. The rate of clearance (K) was calculated
from the formula K=0.693/t, (Sljivi6, 1970).
Distribution of 51Cr-labelled SRBC. Sheep
red blood cells obtained from blood in
Alsever's solution (Difco Laboratories) were
washed x 3 in ice-cold PBS (pH 7.2) and
labelled with 51Cr (sodium chromate B.P.,
Radiochemical Centre, Amersham, England)
on the day of the experiment. To 041 ml
packed erythrocytes was added 75 ,uCi in
0 3 ml PBS and the mixture incubated at
room temperature for 1 h. After 4 washes, a
10% erythrocyte suspension was prepared
and 0-1 ml injected i.v. via a lateral tail vein.
Mice were killed by cervical dislocation 1 h
after injection and livers and spleens dissected
out. Excess blood was removed with filter
paper, and whole organs placed in 5ml plastic
tubes (Sarstedt, West Germany). Radio-
activity was measured in a Wilj 2001 auto-
matic gamma counter and results expressed
as percentage total injected dose.
Histology. Liver and spleen were fixed in
10% neutral buffered formalin. Paraffin
sections were cut at 5 ,um and stained with
haematoxylin and eosin. Gram and Twort
stains were used to identify C. parvrum within
the tissues.
Statistics. A two-tailed Student's t test
mwas used for statistical analysis.
RESULTS
Effect ofC. parvum on tumourgrowth
I.p. injection of 1-4 mg C. parvum 24 h
before the standard tumour inoculum
(0.2 ml) inhibited tumour growth. On Day
11, the number of free ascites cells in C.
parvum-injected animals (5.7 + 0*7 x 108)
was significantly lower (P< 0.0005) than
that (9.9 + 2.1 x 108) in saline-injected
controls.
Effects of C. parvum and tumour on organ
weights
Liver weights in mice injected with C.
parvum or tumour, and in animals given
C. parvum 24 h before tumour are shown
in Fig. 1. By Day 4, there was significant
liver enlargement (P < 0.025) in each
group. Over the next 3 days, a further
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highly significant (P< 0.0005) increase in
liver weight occurred in response to C.
parvum. This effect was not apparent in
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FIG. 1.-Liver weights at various times after
tumour injection in normal (DO) and C.
parvum treated (*) mice. Results obtained
in animals injected with C. parvum alone
(Day -1) are also shown (0). Values are
means +s.d. obtained from groups of 5-8
mice.
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FIG. 2.-Spleen weights at various times after
tumour injection in normal (DO) and C.
parvum-treated (*) mice. Results obtained
in animals injected with C. parvum alone
(Day - 1) are also shown (0). Values are
means + s.d. obtained from groups of 5-8
mice.
animals bearing tumour until Day 11.
Tumour alone caused no further significant
liver enlargement after Day 4.
Animals injected with C. parvum also
showed pronounced splenomegaly (Fig. 2),
a significant weight increase being re-
corded on Day 4 (P< 0.0025), with further
highly significant increases on Days 7 and
11. There was no dramatic increase in
spleen weight in those animals injected
with C. parvum and tumour; although
small but significant increases, compared
to normal animals, were observed in this
group on Days 4 and 7 (P< 0.05) the
values did not differ from those in mice
given tumour alone. By Day 11, however,
there was a significant difference in spleen
weights between the latter two groups,
due principally to atrophy ofthe spleen in
animals given tumour alone.
Histological appearances of liver and spleen
Typical periportal and parenchymal
lymphohistiocytic inflammation with well-
rounded granulomas was observed in
livers of C. parvum-injected mice ex-
amined 5-12 days after injection of the
microorganism (Fig. 3a). Animals which
also received tumour showed a marked
reduction in the degree of inflammatory-
cell infiltration and a striking reduction in
granuloma formation (Fig. 3b). In the
spleen, the degree of macrophage pro-
liferation, constituting the mantle zone,
which was very pronounced in response to
C.parvum (Fig. 4a), was markedly reduced
in animals which also received tumour
(Fig. 4b). Examination of Gram- and
Twort-stained sections of liver and spleen
from all C. parvum-injected animals re-
vealed the microorganism within mono-
nuclear phagocytes. The presence of
tumour did not affect the uptake or dis-
tribution of the microorganism within
these tissues.
Effect of C. parvum and tumour on phago-
cytic index (K)
The influence of C. parvum on the rate
of clearance of colloidal carbon from the
bloodstream, and the effect of tumour
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FIG. 3. (a) Liver from mouse injected with C. parvum 8 days previously, showing well formed,
rounded granulomas. H. & E. x 150. (b) Liver from mouse injected with tumour 24 h after C.
parvum (8 days previously). Note reduction in degree of lymphohistiocytic infiltrate, and virtual
absence of granulomas. H. & E. x 150.
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FIG. 4. (a) Spleen from mouse injected with C. parvum 8 days previously. Note proliferation ofpale-
staining macrophages at the margin (mantle zone) of white pulp. H. & E. x 150. (b) Spleen, from
mouse injected with tumour 24 h after C. parvum (8 days previously). Note reduction in macro-
phage proliferation. H. & E. x 150.
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Day 4 and did not differ significantly from
normal on Days 7 and 11.
Effects of C. parvum and tumour on the
organ distribution of 51Cr-labelled SRBC
The percentages of injected radio-
activity taken up within liver and spleen
on various days after C. parvum, C.
parvurn +tumour or tumour alone are
shown in Table I. Four days after C.
TABLE I. Inf uence of C. parvum and
tumour-carriage on the organ distribution
of 51Cr-labelled SRBC
LiVerl
610+8-1
66-5 +938
50-7 + 8-5*
35-1 + 10-2***
29-4+ 12.0***
60-4 + 7-6
52-4 +9.4*
25-1 + 8.8***
56-1 + 12-9
62-9+8-7
I)ay afterA
C.
pu(rvum Tumour
4 _
11
Days
FIG. 5. Phagocytic iildex (K) at various
times after tumour injection in normal
(Li) and C. poirvum-treate(l (-) mice. The
K values obtained in animals injected with
C. parvum alone (Day -1) are also shown
(0). Values are means + s.d. obtained
from grotups of 4-8 mice. The slhadied area
represents the value in normal control
animals.
carriage in normal and C. parvum-injected
mice is shown in Fig. 5. Injection of the
microorganism alone caused a highly
significant 3-fold increase in K within
3 days (P<0.0005) and higher clearance
rates were maintained throughout the 11-
day course ofthe experiment. However, in
mice which also received tumour 24 h
after C. parvum, no significant increase
was seen until Day 7, and indeed an initial
significant decrease, compared to values in
normal animals, was seen 1 day after
tumour-cell injection. This depression in
K was also recorded 1 and 2 days after
injection of tumour alone. In the latter
group normal values were restored by
8
4
8
3
7
:3
7
Values ate means + s.d. from groups of 5-10
mice. Asterisks iin(licate significance of (lifference
fiom tuntreatedl controls: *P<0-05; **JP<0 005;
***P < 0(0005.
parvuum there was a significant fall in
uptake of 51Cr by the liver. A further
decrease in hepatic uptake was seen on
Day 8 after C. parvum. At the same time,
there was a significant increase in radio-
activity within the spleen, which was not,
however, sufficient to completely account
for the loss in uptake by the liver.
Mice injected with tumour 24 h after
the microorganism showed a highly sig-
nificant decrease in hepatic phagocytosis
within 1 day. This was accompanied by
a shift in distribution of51Cr to the spleen.
Thereafter, uptake of 51Cr by the liver
and spleen did not differ from normal,
except for a small but significant decrease
in the liver on Day 8.
Tumour alone also caused an initial,
significant depression of hepatic phago-
cytosis (Day 1), with concomitant in-
crease in activity within the spleen.
14
12
10
8
6
4
2
0
°0 tiptake
a.I,
0 1 2 4 7
Spleen
10-4 + 4-5
5-8+2-3*
8-5 + 6-3
16.2+7 4*
1939 + 8.7**
8-4 + 3-5
8-4+4-6
32 2 + 8.8***
1.3-3 +6(4
12 + 0-2***
nomommomm
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TABLE II.-Ifnuence of ascitic fluid on phagocytic activity (K) and organ distribution of
5lCr-labelled SRBC
Day aftert
MS Kx 100
- 3:4+0-9
1 3 5+-0-8
- 116 + 05***
- 223 + 0.4**
1 62+1 7
- 26+ 1.2**
1 98+50
- 31 + 0.9**
% Uptake
Liver Spleen
61-0+ 8-1 10O4+ 4-5
632±+ 14 1 8 7+5 2
24-5+ 13.1*** 35.6+ 8.4***
14 6 + 7.9*** 35 6 + 13.0***
58 8+5 4 14 2+4-4
32 5+ 16.2*** 32 1 + 18.0**
507+85 85+63
14.5+ 9.4*** 27.7+ 8.6***
t Ascitic fluid or NIS (1Iml) on Day 0. HT = heat treated (30min at 56°C). NMS = normal mouse serum.
** P<O0005. *** P<00005.
Thereafter (Days 3 and 7) liver uptake
was normal, and although on Day 3
splenic activity did not differ from that in
uninjected controls, there was pronounced
inhibition of splenic activity on Day 7.
Effect of ascites ftuid and C. parvum on K
and organ distribution of 5lCr-SRBC
Injection of 1 ml normal mouse serum
(NMS) i.p. 24 h previously had no effect on
K or the organ distribution of labelled
SRBC (Table II). In contrast, i.p. injec-
tion of 1 ml fresh or heat-treated cell-free
ascites fluid caused a significant depression
in K and hepatic uptake of SRBC. This
was accompanied by increased phagocytic
activity in the spleen.
In mice treated with C. parvum, 24 h or
4 days before carbon or SRBC injection,
ascitic fluid also depressed K, with
attendant increases in the proportion of
SRBC incorporated within the spleen.
This depression in hepatic phagocytosis
resulting from injection of ascitic fluid
was transient, however, since 3 days after
its injection K values in either saline- or
C. parvum-treated mice were restored to
normal (data not presented).
DISCUSSION
In this study we have confirmed the
potent reticuloendothelial activating pro-
perties of C. parvum, and have found, in
keeping with Castro (1974b), that its
prophylactic i.p. administration inhibits
growth of an ascites tumour given by the
same route. We have, in addition, shown
that injection of tumour suspensions and
ascitic fluid can modulate some responses
of the mononuclear phagocyte system to
C. parvum. Although in this study we have
not evaluated the influence of the tumour
on the activity of peritoneal macrophages,
the decrease in K values, alterations in
antigen distribution and marked reduc-
tions both in granuloma formation within
the liver and in cell proliferation within
the mantle zone of the spleen, provide
good evidence that the LAC depresses at
least these responses of the MPS to C.
parvum.
The ability of LAC to reduce hepato-
splenomegaly in C. parvum-injected mice
itself suggests that the tumour influences
the response of liver and spleen to the
microorganism. Changes induced by C.
parvum include Kupffer-cell proliferation
and recruitment of mononuclear phago-
cytes (Castro, 1974a; McBride et al., 1974;
Otu et al., 1976; Sljivic & Warr, 1975),
production of granulomas within the liver
(Halpern et al., 1963; Sljivic & Warr,
1975) and pronounced expansion of the
splenic red and white pulp (McBride et al.,
1974; Otu et al., 1976). Clearly, a reduction
in intensity of these changes would pro-
duce less marked hepatosplenomegaly,
and indeed our histological observations
confirm that this was the case. It may be
argued that the reduction in cell prolifera-
tion and granuloma production could
Fluid N:
1 (HT)
PIretreatment
Saline
(-24hi)
C. parvrrn
(-24h)
C. p"rvum
(- 4 days)
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reflect diversion ofinflammatory cells into
the peritoneal cavity by the stimulus of
the growing tumour. Eccles & Alexander
(1974) reported sequestration of macro-
phages within rat fibrosarcomas, but
Normann (1978) found that peritoneal
macrophage accumulation was impaired
in animals bearing an ascites tumour. We
have found only a small proportion of
macrophages, identified by morphological
and functional criteria, within the pro-
liferating LAC (Thomson, Pugh-Humph-
reys & Reid, unpublished) and it is there-
fore very unlikely that accumulation of
inflammatory cells within the tumour
accounts for the observed effects on liver
and spleen. An alternative explanation is
that the LAC exerts an inhibitory effect on
macrophage differentiation and function.
There is evidence that tumour carriage
and serum from tumour bearers can
inhibit development of macrophage
colonies derived from marrow (Otu et al.,
1.977) and that malignant tumours impair
the inflammatory response to i.p. injection
ofnonspecific stimuli (Eccles & Alexander,
1974; Snyderman et al., 1975; Meltzer &
Stevenson, 1977). In addition, key re-
sponses of macrophages, such as phago-
cytosis of opsonized red cells, chemotactic
migration, bacterial resistance and their
participation in anti-tumour immunity
are affected by tumours or their extracts
(Pike & Snyderman, 1976; Meltzer &
Stevenson, 1977; Normann & Sorkin,
1976; North et al., 1978; Nelson & Nelson,
1978). We have shown in this study that
LAC inhibits phagocytic activity, meas-
ured systemically in terms of colloid
clearance from the blood, in both normal
and C. parvum-injected mice. Our results
are therefore in keeping with those of
North et al. (1976) who found that s.c.
injection oftumour cellsgreatlysuppressed
bacterial destruction by Kupffer cells in
normal and C. parvum-injected mice. The
present results also show that the LAC
tumour affects organ distribution ofradio-
labelled SRBC; the progressive reduction
in splenic phagocytosis in tumour-bearing
mice is consistent with impaired macro-
phage function and with reduced coloniza-
tion of the spleen by these cells.
Injection of LAC caused an initial,
transient reduction in the phagocytic
index (K). OtLI et al. (1977) observed a
triphasic effect ofLewis lutng carcinonma on
K values. They reported an initial de-
pression, which was followed by an
increase and subsequent decrease in K.
This suppression of macr-ophage fuinction
during the initial phase of tumour growth
could clearly facilitate evasion bv the
tumour of immunological surveillance. As
Snyderman et al. (1977) have suggested,
once this inhibitory effect has been over-
come systemically, the ttumour may be
sufficiently well established to render
destruction by immunological means in-
effective. In the present st,udy, the initial
decrease in hepatic phagocytosis cmused
by the tuimoutr was accompanied by a shift
in antigen distribution towards the spleen
in both normal and C. parrurn-injected
hosts. This enhancement ofantigen uiptake
by the spleen, concomitant with depressed
Kupffer-cell activity, also occuLrs after
injection of antimacrophage agents such
as carrageenan and silica, and persists for
up to 72 h (Levy & WNlheelock, 1975;
Fowler & Thomson, 1978).
The capacity of ascitic fluid to depress
phagocytic activity observed in this study
is consistent with the work of Hrsak &
Marotti (197:3, 1974), who found that a
single i.p. injection of Ehrlich ascites
carcinoma fluid impaire(d hepatic and
splenic phagocytosis, and causedprolonged
suppression of humoral immunity. Others
have reported that ascitic fluid from the
same tumour inhibits skin allograft re-
jection in the mouse (McCarthy et al.,
1968). These findings led Hrsak & Marotti
(1974) to suggest thlat Ehrlich ascites
tumouir fluiid contains a factor, stuch as
that described earlier by Holmberg (1962)
which inhibits antigen handling by macro-
phages. It seems likely that a similar
factor may be responsible for depression
of macrophage activity in the present
study. Characterization of the active com-
ponent(s) an(d its possible resemblance to
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other anti-inflammatory tumour products
already described (James, 1977) is cur-
rently under investigation in this labora-
tory.
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